Bank Of New York Mellon Corp Pacira Bio Sciences, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $17.9 Million - $26.9 Million	467,553 New	467,553 $18.1 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $461,262 - $530,127	9,002 Added 1.9%	483,768 $25.7 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $1.97 Million - $3.12 Million	-38,179 Reduced 7.44%	474,766 $27.7 Million
Q1 2022 May 11, 2022	BUY	$60.03 - $76.49 $958,078 - $1.22 Million	15,960 Added 3.21%	512,945 $39.1 Million
Q4 2021 Feb 11, 2022	BUY	$47.97 - $62.21 $903,035 - $1.17 Million	18,825 Added 3.94%	496,985 $29.9 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $298,990 - $335,433	5,472 Added 1.16%	478,160 $26.8 Million
Q2 2021 Aug 11, 2021	SELL	$59.18 - $69.99 $629,024 - $743,923	-10,629 Reduced 2.2%	472,688 $28.7 Million
Q1 2021 May 13, 2021	SELL	$59.31 - $78.82 $145,428 - $193,266	-2,452 Reduced 0.5%	483,317 $33.9 Million
Q4 2020 Feb 09, 2021	SELL	$50.47 - $66.26 $1.34 Million - $1.76 Million	-26,601 Reduced 5.19%	485,769 $29.1 Million
Q3 2020 Nov 12, 2020	SELL	$51.97 - $63.0 $585,234 - $709,443	-11,261 Reduced 2.15%	512,370 $30.8 Million
Q2 2020 Aug 12, 2020	BUY	$30.8 - $52.47 $997,766 - $1.7 Million	32,395 Added 6.59%	523,631 $27.5 Million
Q1 2020 May 06, 2020	SELL	$28.4 - $50.7 $227,881 - $406,816	-8,024 Reduced 1.61%	491,236 $16.5 Million
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $231,766 - $298,915	6,383 Added 1.3%	499,260 $22.6 Million
Q3 2019 Nov 07, 2019	BUY	$35.66 - $44.99 $9.99 Million - $12.6 Million	280,165 Added 131.71%	492,877 $18.8 Million
Q2 2019 Aug 12, 2019	SELL	$36.57 - $47.97 $218,908 - $287,148	-5,986 Reduced 2.74%	212,712 $9.25 Million
Q1 2019 May 14, 2019	BUY	$36.47 - $42.17 $304,962 - $352,625	8,362 Added 3.98%	218,698 $8.32 Million
Q4 2018 Feb 11, 2019	SELL	$41.31 - $52.16 $481,096 - $607,455	-11,646 Reduced 5.25%	210,336 $9.05 Million
Q3 2018 Nov 09, 2018	SELL	$32.85 - $52.0 $9,986 - $15,808	-304 Reduced 0.14%	221,982 $0
Q2 2018 Aug 06, 2018	SELL	$27.5 - $39.8 $104,197 - $150,802	-3,789 Reduced 1.68%	222,286 $7.13 Million
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $87,481 - $135,249	2,918 Added 1.31%	226,075 $7.04 Million
Q4 2017 Feb 09, 2018	BUY	$31.85 - $46.95 $7.11 Million - $10.5 Million	223,157	223,157 $10.2 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account